Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Detalhes bibliográficos
Main Authors: Macbeth, F, Griffiths, G, Noble, S, Burns, S, Maughan, T
Formato: Journal article
Publicado em: 2009

Registos relacionados